Jonathan H Kaufman
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.7MFederal grants as PI10 awards
3Patents grantedLatest Nov 12, 2024
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
10 awards · $4.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 12, 2023 | NIH | SBIR Phase II Phenotyping Interstitial Cystitis/Bladder Pain Syndrome by ICE-MRI Based Bladder Permeability Assay | $680K | Lipella Pharmaceuticals Inc. |
| Sep 15, 2022 | NIH | SBIR Phase II Phenotyping Interstitial Cystitis/Bladder Pain Syndrome by ICE-MRI Based Bladder Permeability Assay | $673K | Lipella Pharmaceuticals Inc. |
| Aug 12, 2019 | NIH | STTR Phase II Measuring Bladder Permeability with MRI Using a Novel Contrast Agent Formulation | $585K | Lipella Pharmaceuticals Inc. |
| Sep 19, 2018 | NIH | STTR Phase II Measuring Bladder Permeability with MRI Using a Novel Contrast Agent Formulation | $656K | Lipella Pharmaceuticals Inc. |
| Aug 1, 2017 | NIH | SBIR Phase I Rapid Point-of-Care Diagnostic Kit for Mosquito Borne Diseases in Urine | $211K | Lipella Pharmaceuticals Inc. |
| May 3, 2016 | NIH | SBIR Phase II Preclinical Development of Tacrolimus for Radiation Cystitis | $630K | Lipella Pharmaceuticals Inc. |
| Sep 16, 2015 | NIH | STTR Phase I Measuring Bladder Permeability with MRI using a Novel Contrast Agent Formulation | $225K | Lipella Pharmaceuticals Inc. |
| Jun 30, 2015 | NIH | STTR Phase II Developing Intravesical Liposomes for Interstitial Cystitis | $373K | Lipella Pharmaceuticals Inc. |
| Jun 10, 2015 | NIH | STTR Phase II Developing Intravesical Liposomes for Interstitial Cystitis Suppliment request for NIH Exhibiting companies at BIO International | $5K | Lipella Pharmaceuticals Inc. |
| May 19, 2015 | NIH | SBIR Phase II Preclinical Development of Tacrolimus for Radiation Cystitis | $648K | Lipella Pharmaceuticals Inc. |
4 patents as inventor
- US 10639278Lipella Pharmaceuticals Inc.May 5, 2020
- US 11357725Lipella Pharmaceuticals Inc.Jun 14, 2022
- US 12138345Lipella Pharmaceuticals Inc.Nov 12, 2024
- US Lipella Pharmaceuticals Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#318
Awards as PI#141
Patents#124
Companies
- Lipella Pharmaceuticals Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.